![]() |
|
|
Vol. 297, Issue 3, 1082-1087, June 2001
Department of Biomedical Sciences, Section of Pharmacology (C.B.,
S.G., M.M.C., G.F., C.M., A.B.) and Section of General Pathology (A.T.,
A.B.), University of Modena and Reggio Emilia, Modena, Italy;
Department of Morphological Sciences and Forensic Medicine, University
of Modena and Reggio Emilia, Modena, Italy (D.Z.); and Department of
Human Pathology, University of Pavia, Pavia, Italy (A.R.B)
The influence of the melanocortin peptide ACTH-(1-24)
(adrenocorticotropin) on the consequences of short-term coronary
ischemia (5 min) followed by reperfusion, and the effect of the
long-acting melanocortin
[Nle4,D-Phe7]
-melanocyte-stimulating
hormone (NDP-MSH) on the damage induced by a permanent coronary
occlusion, were investigated in anesthetized rats. Ischemia was
produced by ligature of the left anterior descending coronary artery.
Reperfusion-induced arrhythmias [ventricular tachycardia (VT),
ventricular fibrillation (VF)] and survival rate within the 5 min
following reperfusion, blood levels of free radicals detected 2 min
after reperfusion by electron spin resonance spectrometry, and
amount of healthy myocardial tissue, measured 72 h after permanent
coronary occlusion on immunohistologically stained serial sections,
were evaluated. Postischemic reperfusion induced VT in all
saline-treated rats, and VF and death in a high percentage of animals
(87%). In rats treated i.v. (2.5 min after coronary occlusion) with
ACTH-(1-24) (0.16-0.48 mg/kg) there was a significantly dose-dependent
reduction in the incidence of arrhythmias and lethality.
Ischemia/reperfusion caused a large increase in free radical blood
levels; treatment with ACTH-(1-24) (0.48 mg/kg i.v.) almost completely
prevented this increase. In rats subjected to permanent coronary
occlusion, the amount of healthy myocardial tissue was much reduced in
saline-treated rats, while in rats treated s.c. with NDP-MSH (0.27 mg/kg every 12 h) it was significantly higher. The present data
demonstrate, for the first time, an unforeseen property of melanocortin
peptides, i.e., their ability to significantly reduce both heart
ischemia/reperfusion injury and size of the ischemic area induced by
permanent coronary occlusion.
This article has been cited by other articles:
![]() |
G. Leoni, H. B. Patel, A. L. F. Sampaio, F. N. E. Gavins, J. F. Murray, P. Grieco, S. J. Getting, and M. Perretti Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion FASEB J, December 1, 2008; 22(12): 4228 - 4238. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kang, K. W. McIntyre, K. M. Gillooly, Y. Yang, J. Haycock, S. Roberts, A. Khanna, T. F. Herpin, G. Yu, X. Wu, et al. A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice J. Leukoc. Biol., October 1, 2006; 80(4): 897 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Giuliani, C. Mioni, D. Altavilla, S. Leone, C. Bazzani, L. Minutoli, A. Bitto, M.-M. Cainazzo, H. Marini, D. Zaffe, et al. Both Early and Delayed Treatment with Melanocortin 4 Receptor-Stimulating Melanocortins Produces Neuroprotection in Cerebral Ischemia Endocrinology, March 1, 2006; 147(3): 1126 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guarini, M. M. Cainazzo, D. Giuliani, C. Mioni, D. Altavilla, H. Marini, A. Bigiani, V. Ghiaroni, M. Passaniti, S. Leone, et al. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway Cardiovasc Res, August 1, 2004; 63(2): 357 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catania, S. Gatti, G. Colombo, and J. M. Lipton Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29. [Abstract] [Full Text] [PDF] |
||||